Acasti Pharma Common Stock Net 2014-2024 | GRCE
Acasti Pharma common stock net from 2014 to 2024. Common stock net can be defined as the value of common equity ownership.
Acasti Pharma Annual Common Stock Net
(Millions of US $) |
| 2024 |
$261 |
| 2023 |
$258 |
| 2022 |
$258 |
| 2021 |
$197 |
| 2020 |
$137 |
| 2019 |
$111 |
| 2018 |
$57 |
| 2017 |
$51 |
| 2016 |
$48 |
| 2015 |
$55 |
| 2015 |
$ |
| 2014 |
$58 |
| 2014 |
$ |
| 2013 |
$29 |
| 2013 |
$ |
Acasti Pharma Quarterly Common Stock Net
(Millions of US $) |
| 2024-06-30 |
$261 |
| 2024-03-31 |
$261 |
| 2023-12-31 |
$261 |
| 2023-09-30 |
$261 |
| 2023-06-30 |
$258 |
| 2023-03-31 |
$258 |
| 2022-12-31 |
$258 |
| 2022-09-30 |
$258 |
| 2022-06-30 |
$258 |
| 2022-03-31 |
$258 |
| 2021-12-31 |
$258 |
| 2021-09-30 |
$258 |
| 2021-06-30 |
$197 |
| 2021-03-31 |
$197 |
| 2020-12-31 |
$162 |
| 2020-09-30 |
$143 |
| 2020-06-30 |
$139 |
| 2020-03-31 |
$137 |
| 2019-12-31 |
$124 |
| 2019-09-30 |
$115 |
| 2019-06-30 |
$97 |
| 2019-03-31 |
$111 |
| 2018-12-31 |
$98 |
| 2018-09-30 |
$61 |
| 2018-06-30 |
$62 |
| 2018-03-31 |
$57 |
| 2017-12-31 |
$56 |
| 2017-09-30 |
$53 |
| 2017-06-30 |
$50 |
| 2017-02-28 |
$51 |
| 2016-11-30 |
$47 |
| 2016-08-31 |
$48 |
| 2016-05-31 |
$48 |
| 2016-03-31 |
$48 |
| 2016-02-29 |
|
| 2015-12-31 |
$47 |
| 2015-09-30 |
$48 |
| 2015-06-30 |
$50 |
| 2015-03-31 |
$55 |
| 2014-12-31 |
$55 |
| 2014-09-30 |
$57 |
| 2014-06-30 |
$56 |
| 2014-03-31 |
$58 |
| 2014-02-28 |
|
| 2013-12-31 |
$45 |
| 2013-09-30 |
$43 |
| 2013-06-30 |
$28 |
| 2013-03-31 |
$29 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-GENERIC DRG |
$0.033B |
$0.000B |
|
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
|
